BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30992230)

  • 1. The metalloprotease ADAM17 in inflammation and cancer.
    Düsterhöft S; Lokau J; Garbers C
    Pathol Res Pract; 2019 Jun; 215(6):152410. PubMed ID: 30992230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
    Schumacher N; Rose-John S
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119141. PubMed ID: 34610348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shedding protease ADAM17: Physiology and pathophysiology.
    Zunke F; Rose-John S
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2059-2070. PubMed ID: 28705384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.
    Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A
    Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
    Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
    Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17.
    Yang G; Cui M; Jiang W; Sheng J; Yang Y; Zhang X
    Aging (Albany NY); 2021 Jun; 13(12):16859-16872. PubMed ID: 34182543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress.
    Adu-Amankwaah J; Adzika GK; Adekunle AO; Ndzie Noah ML; Mprah R; Bushi A; Akhter N; Huang F; Xu Y; Adzraku SY; Nadeem I; Sun H
    Front Cell Dev Biol; 2021; 9():732952. PubMed ID: 34966735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.
    Matthews AL; Noy PJ; Reyat JS; Tomlinson MG
    Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses.
    Yan I; Schwarz J; Lücke K; Schumacher N; Schumacher V; Schmidt S; Rabe B; Saftig P; Donners M; Rose-John S; Mittrücker HW; Chalaris A
    J Leukoc Biol; 2016 May; 99(5):749-60. PubMed ID: 26561568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis.
    Li X; Maretzky T; Perez-Aguilar JM; Monette S; Weskamp G; Le Gall S; Beutler B; Weinstein H; Blobel CP
    J Cell Sci; 2017 Mar; 130(5):868-878. PubMed ID: 28104813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distance dependent shedding of IL-6R.
    Düsterhöft S; Bartels AK; Koudelka T; Lilienthal E; Schäfer M; Garbers C; Tholey A; Grötzinger J; Lorenzen I
    Biochem Biophys Res Commun; 2020 May; 526(2):355-360. PubMed ID: 32222277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.
    Stolarczyk M; Scholte BJ
    Mediators Inflamm; 2018; 2018():1067134. PubMed ID: 29540993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.
    Oldefest M; Düsterhöft S; Desel C; Thysen S; Fink C; Rabe B; Lories R; Grötzinger J; Lorenzen I
    Biochem J; 2015 Jun; 468(3):507-18. PubMed ID: 25846075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted truncation of the ADAM17 cytoplasmic domain in mice results in protein destabilization and a hypomorphic phenotype.
    Lora J; Weskamp G; Li TM; Maretzky T; Shola DTN; Monette S; Lichtenthaler SF; Lu TT; Yang C; Blobel CP
    J Biol Chem; 2021; 296():100733. PubMed ID: 33957124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ADAM17 during liver damage.
    Al-Salihi M; Bornikoel A; Zhuang Y; Stachura P; Scheller J; Lang KS; Lang PA
    Biol Chem; 2021 Aug; 402(9):1115-1128. PubMed ID: 34192832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Interleukin-6 and Interleukin-11 receptor cleavage.
    Lokau J; Wandel M; Garbers C
    Int J Biochem Cell Biol; 2017 Apr; 85():6-14. PubMed ID: 28143719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains.
    Tang B; Li X; Maretzky T; Perez-Aguilar JM; McIlwain D; Xie Y; Zheng Y; Mak TW; Weinstein H; Blobel CP
    FASEB J; 2020 Apr; 34(4):4956-4969. PubMed ID: 32103528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
    Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
    EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.
    Schumacher N; Schmidt S; Schwarz J; Dohr D; Lokau J; Scheller J; Garbers C; Chalaris A; Rose-John S; Rabe B
    J Immunol; 2016 Nov; 197(9):3705-3715. PubMed ID: 27698010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM17: a molecular switch to control inflammation and tissue regeneration.
    Scheller J; Chalaris A; Garbers C; Rose-John S
    Trends Immunol; 2011 Aug; 32(8):380-7. PubMed ID: 21752713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.